참고문헌
- Ashkenazi A, Pai RC, Fong S, et al (1999). Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest, 104, 155-62. https://doi.org/10.1172/JCI6926
-
Chen FC, Zhang F, Zhang ZJ, et al (2013). Tumor necrosis factor-
$\alpha$ gene polymorphisms and risk of oral cancer: evidence from a meta-analysis. Asian Pac J Cancer Prev, 14, 7243-9. https://doi.org/10.7314/APJCP.2013.14.12.7243 - Choi SA, Hwang SK, Wang KC, et al (2011). Therapeutic efficacy and safety of TRAIL producing human adipose tissue - derived mesenchymal stem cells against experimental brainstem glioma. Neuro-Oncol, 13, 61- 9. https://doi.org/10.1093/neuonc/noq147
- Duiker EW, Mom CH, de Jong S, et al (2006). The clinical trail of TRAIL. Eur J Cancer, 42, 2233-40. https://doi.org/10.1016/j.ejca.2006.03.018
- Grisendi G, Bussolari R, Cafarelli L, et al (2010). Adiposederived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Res, 70, 3718-29. https://doi.org/10.1158/0008-5472.CAN-09-1865
- HengXu, Yan-Na Tian, Bo-Ying Dun, et al (2014). A Novel Monoclonal Antibody Induces Cancer Cell Apoptosis and Enhances the Activity of Chemotherapeutic Drugs. Asian Pac J Cancer Prev, 15, 4423-8. https://doi.org/10.7314/APJCP.2014.15.11.4423
- Jiang L, Hao JL, Jin ML,et al (2013). Effect of embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells. Asian Pac J Cancer Prev, 14, 6115-20. https://doi.org/10.7314/APJCP.2013.14.10.6115
- Kay NE, Shanafelt TD, Strege AK, et al (2007). Bone biopsy derived marrow stromalelements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced celldeath and facilitates an “angiogeneic switch”. Leuk Res, 31, 899-906. https://doi.org/10.1016/j.leukres.2006.11.024
- Kim SM, Lim JY, Park SI, et al (2008). Gene therapy using TRAIL-secreting human umbilical cord blood derived mesenchymal stem cells against intracranial glioma. Cancer Res, 68, 9614-23. https://doi.org/10.1158/0008-5472.CAN-08-0451
- Lagneaux L, Delforge A, Bron D, et al (1998). Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood, 91, 2387-96.
- Loebinger MR, Eddaoudi A, Davies D, et al (2009). Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res, 69, 4134-42.
- Mahalingam D, Szegezdi E, Keane M, et al (2009). TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat Rev, 35, 280-8. https://doi.org/10.1016/j.ctrv.2008.11.006
- Messmer BT, Messmer D, Allen SL, et al (2005). In vivomeasurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest, 115, 755-64. https://doi.org/10.1172/JCI23409
- Montserrat E (2002).Current and developing chemotherapy for CLL. Med Oncol.19, 11-19. https://doi.org/10.1385/MO:19:1:11
- Nwabo Kamdje AH, Bassi G, PacelliL, et al (2012). Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy. Blood Cancer Journal, 2, 73 https://doi.org/10.1038/bcj.2012.17
- Panayiotidis P, Jones D, Ganeshaguru K, et al (1996). Human bone marrow stromal cellsprevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol, 92, 97-103. https://doi.org/10.1046/j.1365-2141.1996.00305.x
- SeiffertM, SchulzA, Ohl S, et al (2010). Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo. Blood, 116, 4223-30. https://doi.org/10.1182/blood-2010-05-284505
- Sprick MR, Weigand MA, Rieser E, et al (2000). FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity, 12, 599-609. https://doi.org/10.1016/S1074-7613(00)80211-3
- Walczak H, Miller RE, Ariail K, et al (1999). Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand In vivo. Nat Med, 5, 157-63. https://doi.org/10.1038/5517
- Wiley SR, Schooley K, Smolak PJ, et al (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673-82. https://doi.org/10.1016/1074-7613(95)90057-8
- Zhao B, Li L, Cui K, et al (2011). Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis. Asian Pac J Cancer Prev, 12, 2675-8.
피인용 문헌
- HMGB1 translocation is involved in the transformation of autophagy complexes and promotes chemoresistance in leukaemia vol.47, pp.1, 2015, https://doi.org/10.3892/ijo.2015.2985
- PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells vol.17, pp.5, 2017, https://doi.org/10.1002/mabi.201600169